virtual health care
Teladoc and Livongo agree to $18.5bn deal, but investors don’t like the terms
Shareholders question the motivation for such a significant price tag for Livongo
05 August 2020 - 18:23
New York/Paris — Teladoc Health, a US supplier of virtual health care, agreed to buy Livongo Health, which helps manage diabetes with connected devices, for about $18.5bn, as the novel coronavirus pandemic spurs demand for remote medicine.
Each Livongo share will be exchanged for 0.5920 shares of Teladoc and $11.33 in cash, the companies said in a statement. At $159 per share, the price is 10% above Livongo’s close on Tuesday. Both boards backed the transaction, in which Teladoc holders will own 58% of the enlarged company...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.